past
decad
rna
revolut
reveal
thousand
noncod
rna
essenti
cellular
regul
misregul
diseas
develop
method
tool
studi
rna
challeng
power
promis
small
molecul
chemic
probe
increasingli
recogn
har
exist
knowledg
compil
list
ligand
report
activ
rna
target
biolog
system
rbind
survey
examin
rna
target
design
discoveri
strategi
chemic
probe
character
techniqu
ligand
discuss
applic
current
tool
identifi
evalu
rnatarget
chemic
probe
suggest
criteria
assess
qualiti
rna
chemic
probe
target
propos
area
new
tool
particularli
need
anticip
knowledg
expedit
discoveri
rnatarget
ligand
next
phase
rna
revolut
field
rna
biolog
explod
recent
year
discoveri
noncod
rna
ncrna
regul
essenti
process
live
organ
process
includ
transcript
translat
evas
bacteria
archaea
well
replic
persist
cellular
transform
virus
within
human
genom
proteincod
gene
vastli
outnumb
regulatori
ncrna
influenc
wide
rang
cellular
function
mani
ncrna
dysregul
implic
driver
variou
human
diseas
includ
metastat
cancer
neurolog
neuromuscular
disord
rna
revolut
radic
chang
understand
role
rna
play
fundament
biolog
rapidli
drive
scientif
innov
method
tool
structur
function
character
rna
molecular
level
howev
difficult
andor
lack
compar
protein
one
import
exampl
develop
chemic
probe
greatli
progress
studi
protein
relat
diseas
challeng
nonribosom
rna
power
chemic
tool
requir
small
molecul
welldefin
biolog
activ
cell
permeabl
select
accur
reliabl
probe
specif
mechanist
phenotyp
question
given
potenti
advantag
small
molecul
chemic
probe
biolog
approach
eg
sirna
aso
crisprca
power
use
approach
tandem
develop
rnatarget
chemic
probe
potenti
greatli
benefit
chemist
biologist
interest
rna
ligand
bind
nonribosom
rna
vitro
report
decad
develop
chemic
probe
evid
specif
small
molecul
rna
engag
cell
anim
model
dramat
increas
last
four
year
recent
studi
report
sever
druglik
small
molecul
target
rang
rna
anim
model
includ
riboswitch
mirna
splice
site
matur
mrna
least
one
current
clinic
trial
multival
ligand
report
target
r
cug
exp
repeat
myoton
dystrophi
type
melanogast
mous
model
recent
success
confirm
select
rna
target
achiev
biolog
system
howev
limit
exampl
year
effort
highlight
challeng
associ
select
probe
rna
recent
compil
rnatarget
bioactiv
ligand
databas
rbind
compris
organ
small
molecul
target
nonribosom
rna
show
activ
cell
cultur
anim
model
survey
compil
updat
includ
chemic
probe
discoveri
may
total
chemic
probe
see
supplementari
materi
rbind
aminoglycosid
exclud
due
establish
nonspecif
bind
behavior
well
peptid
oligonucleotid
due
distinct
medicin
chemistri
properti
chemic
probe
divid
two
class
monoval
tradit
druglik
small
molecul
sm
multival
ligand
mv
alkyl
aryl
peptidyl
linker
multipl
bind
moieti
previou
work
compar
physicochem
structur
spatial
properti
small
molecul
fdaapprov
drug
well
rnabind
ligand
without
report
biolog
activ
analysi
reveal
sever
key
differ
librari
turn
use
bia
small
molecul
toward
biolog
rna
target
addit
work
curat
collect
allow
us
gain
insight
rna
element
target
ii
design
discoveri
strategi
util
iii
cellulo
character
chemic
probe
herein
discuss
insight
highlight
uniqu
exampl
consid
need
establish
standard
cellbas
select
conclud
propos
futur
direct
util
current
prospect
chemic
biolog
toolbox
expedit
discoveri
chemic
probe
rna
chemic
probe
target
distinct
rna
element
includ
bacteri
fungal
human
viral
system
figur
although
overlap
target
observ
small
molecul
probe
wider
rang
rna
cell
cultur
multival
ligand
figur
common
small
molecul
target
transactiv
respons
element
tar
rna
wellstudi
frequent
screen
rna
bind
viral
protein
tat
disrupt
interact
reduc
viral
product
repres
altern
strategi
hiv
first
rnatarget
chemic
probe
develop
tar
rna
includ
tetraaminoquinozalin
ec
valu
ic
valu
respect
chronic
infect
hiv
cell
model
hand
one
bioactiv
small
molecul
identifi
fungal
target
specif
candida
albican
lsu
group
ribozym
essenti
ribozym
desir
antifung
target
lead
fail
ribosom
assembl
mutat
absent
human
genom
small
molecul
chemic
probe
demonstr
efficaci
anim
model
target
seven
uniqu
rna
element
bacteri
human
system
one
recent
exampl
target
gquadruplex
structur
locat
untransl
region
utr
human
vascular
endotheli
growth
factor
hvegf
mrna
angiogen
growth
factor
involv
tumor
progress
breast
cancer
mous
model
small
molecul
show
antitumor
efficaci
similar
doxorubicin
fewer
indic
side
effect
multival
chemic
probe
target
fewer
distinct
rna
element
uniqu
ligand
target
nucleotid
repeat
expans
figur
sever
advantag
target
rna
repeat
long
repeat
stretch
typic
present
elsewher
human
genom
ii
nuclear
local
minim
competit
ribosom
rna
iii
target
motif
separ
specif
distanc
anoth
target
interest
heat
shock
respons
element
factor
mrna
e
coli
rna
element
contain
rare
perfectli
pair
threeway
junction
stabil
symmetr
triptycenebas
molecul
form
distinct
shapeselect
fit
stabil
result
reduct
translat
gfp
fusion
protein
could
potenti
lead
antimicrobi
activ
addit
chemic
probe
show
efficaci
anim
model
target
two
rna
element
r
cug
exp
repeat
oncogen
rna
suppress
translat
proapoptot
protein
mous
model
tripl
neg
breast
cancer
modular
ligand
design
target
drosha
process
site
rna
led
statist
signific
reduct
tumor
size
chang
rna
protein
level
consist
propos
mode
action
notabl
examin
list
expos
rnadriven
process
diseas
still
lack
function
chemic
probe
ideal
rna
target
defin
function
site
andor
clear
phenotyp
also
high
abund
sever
untarget
rna
rang
archaeal
ncrna
oncogen
lncrna
meet
criteria
mani
monoval
ligand
discov
tradit
screen
method
approxim
onethird
rna
ligand
interact
identifi
follow
approach
focusedscreen
fc
highthroughput
screen
ht
ht
follow
lead
optim
htslo
figur
survey
fc
defin
use
bias
librari
typic
base
prior
knowledg
particular
chemotyp
bind
rna
element
contrast
fc
librari
molecul
specif
design
explor
structureact
relationship
classifi
lead
optim
lo
start
point
sever
fc
librari
andor
small
molecul
identif
strategi
includ
rnabind
natur
product
chemic
similar
search
scaffoldbas
synthesi
figur
caution
rel
success
variou
approach
evalu
sinc
fail
attempt
typic
document
literatur
hit
rate
one
benchmark
use
assess
effici
screen
note
prior
discuss
comparison
across
studi
interpret
caution
definit
small
molecul
lead
specif
assay
use
primari
screen
control
util
assay
number
falseposit
neg
highli
variabl
alway
report
rna
small
molecul
interact
discov
ht
fc
report
hit
rate
compar
screen
approach
primari
screen
primari
librari
figur
higher
hit
rate
found
fc
approach
provid
compel
evid
fc
effici
rna
target
known
protein
target
move
forward
character
addit
rna
tertiari
structur
identif
novel
rnabind
chemotyp
expedit
fc
approach
discov
biolog
activ
rnatarget
ligand
hit
rate
vari
wide
within
type
primari
screen
primari
librari
comparison
support
potenti
mani
distinct
path
toward
rna
ligand
discoveri
specif
aspect
librari
screen
design
discuss
small
molecul
discov
ht
typic
larg
librari
n
small
molecul
includ
three
corpor
librari
nih
small
molecul
repositori
tabl
select
exampl
smaller
librari
well
fdaapprov
drug
n
ucla
academ
librari
n
importantli
report
explicitli
state
librari
filter
yield
small
molecul
favor
medicin
chemistri
proper
samino
acid
conjug
screen
approach
tie
prior
screen
success
proteintarget
drug
discoveri
one
report
identifi
bioactiv
ligand
fragmentbas
librari
commerci
librari
optim
scaffold
yield
four
addit
molecul
target
influenza
rna
promot
ic
valu
rang
cellbas
luciferas
assay
similarli
two
report
yield
bioactiv
small
molecul
natur
productbas
librari
synthet
librari
academ
librari
screen
contain
fewer
small
molecul
yet
identifi
ligand
bind
modul
gquadruplex
structur
locat
utr
two
distinct
mrna
promis
small
molecul
discov
varieti
ht
librari
suggest
biolog
activ
rnabind
ligand
found
subset
current
small
molecul
chemic
space
valid
explor
space
could
lead
greater
effici
success
identifi
bioactiv
lead
well
rnaprivileg
chemotyp
expect
fc
use
smaller
librari
typic
contain
fewer
small
molecul
tabl
largest
fc
librari
n
academ
librari
design
chemic
similar
search
bisbenzimidazol
similar
core
shown
prefer
nucleotid
intern
loop
addit
librari
filter
favor
medicin
chemistri
properti
screen
result
three
lead
bound
r
cug
exp
vitro
ii
led
statist
signific
decreas
ctnt
minigen
exon
inclus
cell
iii
select
minigen
r
cug
repeat
compar
minigen
without
repeat
fc
also
encompass
rna
structureguid
design
includ
two
studi
util
molecular
model
identifi
ligand
structur
similar
guanin
xptpbux
riboswitch
anoth
structureguid
approach
small
librari
pterphenylenebas
ligand
design
mimic
rev
proteinbind
partner
rev
respons
element
rre
lead
select
dock
one
ligand
disrupt
revrr
interact
vitro
ic
inhibit
replic
ic
valu
exhibit
ontarget
effect
via
rreluciferas
report
assay
ic
valu
identifi
success
report
biolog
activ
ligand
small
molecul
librari
bias
gener
rnabind
recent
chemic
compani
design
focus
librari
chemdiv
nucleic
acid
ligand
http
wwwchemdivcomnucleicacidligand
otava
chemic
rna
target
librari
http
wwwotavachemicalscomproductstargetedlibrariesandfocusedlibrariesrnabind
howev
success
librari
yet
report
date
success
fc
strategi
util
knowledg
rna
structur
andor
small
molecul
binder
neither
known
mani
therapeuticallyrelev
rna
primari
screen
assay
small
molecul
categor
comput
vitro
cellbas
figur
list
contain
wide
rang
primari
screen
assay
limit
exampl
assay
use
multipl
target
major
chemic
probe
discov
vitro
primari
screen
assay
n
fewer
cellulo
silico
exampl
vitro
primari
screen
rna
protein
displac
assay
figur
includ
fluorescencebas
assay
reson
energi
transfer
fret
fluoresc
anisotropi
radiolabelbas
method
mobil
shift
scintil
proxim
filtrat
assay
one
rather
uniqu
assay
util
molecular
beacon
approach
probe
stabil
stem
loop
presumpt
structur
switch
locat
pack
domain
destabil
bind
gag
protein
prior
packag
viru
assay
termin
end
rna
label
tet
fluorophor
blackhol
quencher
respect
presenc
gag
protein
rna
construct
becam
singl
strand
fluoresc
turn
small
molecul
stabil
fold
hairpin
form
rna
gagpromot
rna
destabil
reduc
fluoresc
quench
research
screen
modest
size
librari
small
molecul
discov
ligand
reduc
viral
product
similar
model
mutat
pack
domain
remain
vitro
assay
consist
two
activitybas
screen
variou
rna
bind
assay
figur
v
competit
dialysi
vi
indic
displac
note
lack
correl
small
molecul
activ
vitro
rna
bind
rna
protein
displac
assay
sometim
report
highlight
import
multipl
assay
andor
choos
relev
assay
particular
system
also
note
screen
lack
correl
observ
vitro
activ
cell
cultur
activ
differ
attribut
mani
factor
includ
small
molecul
uptak
local
metabol
specif
offtarget
effect
target
avail
due
bind
macromolecul
metabolit
nonetheless
emphas
success
vitro
assay
mention
develop
rna
bioactiv
valuabl
insight
gain
ligand
discov
vitro
rna
assay
without
report
biolog
activ
cellbas
screen
second
common
primari
screen
assay
ht
fc
approach
figur
often
prefer
screen
bacteri
viral
rna
target
except
splice
assay
human
serotonin
receptor
mrna
green
fluoresc
protein
gfp
report
use
evalu
inclus
exclus
particular
exon
bacteri
viral
rna
cellbas
studi
also
util
report
system
gfp
lacz
gene
well
tradit
phenotyp
screen
growth
inhibit
cell
death
one
particular
exampl
ligand
screen
growth
inhibit
assay
escherichia
coli
without
supplement
riboflavin
differenti
supplement
allow
research
specif
probe
riboflavin
pathway
confirm
fmn
riboswitch
target
ribocilb
addit
one
report
measur
enzym
activ
antigen
product
addit
cell
death
measur
assess
antivir
activ
given
success
cellbas
assay
like
offer
unforeseen
promis
primari
screen
assay
discov
rnatarget
probe
highthroughput
focus
comput
screen
use
identifi
four
small
molecul
figur
two
small
molecul
identifi
dock
experiment
determin
structur
tar
rre
rna
anoth
exampl
small
molecul
model
xray
diffract
structur
xptpbue
guanin
riboswitch
aptam
nativ
ligand
remov
criteria
geometr
constraint
hydrogen
bond
pattern
molecul
planar
use
assess
fit
ligand
lead
select
two
small
molecul
one
antimicrobi
activ
gramposit
bacteria
speci
test
select
speci
guaa
gene
riboswitch
control
fourth
exampl
util
computationallypredict
structur
sever
acut
respiratori
syndrom
coronaviru
sarscov
pseudoknot
librari
small
molecul
dock
predict
structur
highest
score
molecul
test
vitro
activitybas
assay
screen
result
biolog
activ
ligand
ic
valu
cellbas
model
addit
advanc
comput
structur
predict
rna
ligand
dock
undoubtedli
lead
improv
comput
primari
screen
thu
effici
experiment
screen
addit
primari
screen
databas
known
rna
motif
small
molecul
interact
inforna
util
identifi
seven
small
molecul
databas
gener
use
librari
versu
librari
approach
name
combinatori
screen
method
small
molecul
immobil
onto
microarray
slide
incub
librari
label
random
rna
secondari
structur
bound
rna
excis
sequenc
assign
fit
score
use
structureact
relationship
sequenc
start
fit
score
reflect
affin
select
given
rna
motif
small
molecul
interact
repres
numer
scale
higher
score
repres
greater
select
util
inforna
databas
comput
experiment
secondari
structur
rna
input
data
search
lead
molecul
propos
strategi
identifi
bioactiv
ligand
five
target
mapt
premrna
bulg
ii
intern
loop
iii
bulg
iv
intern
loop
v
intern
loop
exampl
ligand
identifi
primari
screen
assay
includ
select
character
four
metabolit
analog
riboswitch
inhibit
contrast
small
molecul
multival
ligand
develop
ration
design
base
secondari
structur
rna
target
figur
gener
develop
began
identif
monoval
ligand
bound
particular
secondari
structur
motif
screen
literatur
search
use
inforna
see
section
method
small
molecul
discoveri
monom
coval
link
select
optim
appropri
size
spacer
sever
multival
ligand
design
inspir
crystal
structur
r
cug
sequenc
lead
ligand
target
r
cug
exp
drosophila
melanogast
model
approach
link
acridin
triaminotriazin
unit
latter
propos
recogn
nonoptim
base
pair
uu
mismatch
januswedg
hydrogen
bond
stack
two
unit
expect
decreas
nonspecif
interc
bind
earli
design
optim
yield
bisamidinium
conjug
mitig
glossi
rough
eye
phenotyp
observ
transgen
drosophila
melanogast
model
differ
approach
util
hoechst
previous
report
bind
guc
intern
loop
hoechst
modifi
contain
azid
handl
coval
link
peptoid
backbon
via
click
chemistri
extens
linker
optim
multival
ligand
identifi
improv
r
cug
exprel
splice
defect
mous
model
one
notabl
except
aforement
design
strategi
use
dynam
combinatori
chemistri
dcc
figur
sever
multival
ligand
deriv
librari
resinbound
cysteinecontain
monom
allow
incub
rna
interest
probe
thousand
multival
ligand
combin
form
coval
yet
revers
disulfid
linkag
binder
highest
affin
thu
enrich
isol
character
valid
rnabind
replac
disulfid
linkag
stabl
bioisoster
method
yield
bioactiv
ligand
two
rna
known
structur
r
cug
exp
statist
signific
improv
splice
observ
mous
model
frameshiftstimul
rna
one
exampl
decreas
viral
infect
ec
valu
correl
frameshift
activ
cell
cultur
power
advantag
dcc
multival
ligand
construct
without
knowledg
rna
structur
includ
larger
complex
tertiari
fold
gener
ration
design
dcc
yield
multival
probe
significantli
increas
affin
specif
rna
target
rel
small
molecul
achiev
high
potenc
biolog
system
larger
molecul
may
requir
develop
tradit
small
molecul
exampl
identifi
support
possibl
success
evalu
target
engag
offtarget
effect
potencyappropri
concentr
criteria
critic
understand
qualiti
chemic
probe
thu
experiment
conclus
curat
collect
chemic
probe
strict
benchmark
relat
criteria
could
includ
due
lack
consist
within
field
next
paragraph
character
techniqu
util
rnatarget
chemic
probe
describ
biolog
system
notabl
exampl
highlight
one
common
valid
experi
bacteri
fungal
system
serial
passag
techniqu
ligand
resist
mutant
grown
presenc
compound
mutat
map
wholegenom
sequenc
addit
confirm
target
engag
result
reveal
offtarget
effect
unexpect
mode
action
select
exampl
perform
serial
passag
experi
multipl
bacteri
strain
measur
bind
affin
mutant
vitro
provid
ad
confid
target
engag
select
case
serial
passag
experi
yield
mutat
isol
ligand
test
mutant
establish
variat
structur
activ
anoth
power
strategi
assess
target
engag
riboswitch
phenotyp
rescu
addit
nativ
ligand
lastli
sever
target
rna
element
regul
express
translat
specif
gene
assess
measur
quantiti
rna
protein
respect
one
studi
went
beyond
measur
expect
transcript
perform
transcriptom
microarray
analysi
gene
involv
mani
differ
cellular
process
observ
repress
consist
riboswitch
inhibit
although
addit
nativ
ligand
fail
rescu
express
sever
gene
indic
potenti
cellular
stress
respons
strategi
genomewid
analys
provid
compel
evid
target
engag
though
must
note
target
specif
alway
lead
biolog
specif
compar
system
chemic
probe
target
viral
rna
less
character
term
target
engag
specif
activ
select
studi
valid
probe
activ
test
mutant
version
viru
close
relat
nativ
virus
notabl
one
report
valid
probe
activ
second
research
group
ensur
reproduc
biolog
effect
rnaspecif
report
system
occasion
use
confirm
ontarget
effect
includ
fusioninduc
gene
stimul
heterolog
tether
viral
protein
report
noteworthi
exampl
assess
offtarget
effect
use
rnaseq
increas
ligand
concentr
absenc
target
rna
experi
cell
reveal
transcript
assay
statist
signific
alter
two
concentr
potenti
reflect
cellular
stress
respons
also
intrigu
biolog
potent
ligand
studi
least
select
analog
vitro
trna
competit
assay
observ
underli
potenti
differ
cellular
activ
versu
vitro
bind
select
thu
import
progress
multipl
ligand
biolog
assay
sever
noteworthi
exampl
probe
ligand
promiscu
andor
select
human
system
multipl
studi
util
genomewid
analys
global
assess
chang
mirna
mrna
splice
level
compar
target
rna
process
toward
direct
assess
chemic
crosslink
isol
pull
chemclip
util
investig
proximitybas
engag
rna
method
ligand
append
nucleicacid
reactiv
modul
eg
chlorambucil
biotin
purif
tag
incub
cell
modifi
ligand
cell
lyse
ligand
captur
streptavidin
bead
bound
target
character
qrtpcr
rnaseq
strategi
well
competit
chemclip
use
character
onand
offtarget
engag
ligand
modul
repeat
expans
mirna
anoth
studi
dual
luciferas
report
assay
util
compar
ligand
bind
four
gquadruplex
structur
includ
rna
interest
three
regulatori
rna
studi
one
exampl
select
within
target
famili
assess
cell
cultur
variou
control
also
use
evalu
ontarget
effect
exampl
impact
chemic
probe
analyz
follow
sirna
knockdown
mrna
follow
inhibit
mtor
signal
pathway
modul
anoth
exampl
overexpress
assess
effect
chemic
probe
phenotyp
likewis
ligand
target
r
cug
exp
test
rna
condit
express
anoth
notabl
exampl
use
rna
immunoprecipit
rip
detect
rnabind
increas
concentr
ligand
identifi
dosedepend
respons
precipit
gquadruplex
specif
antibodi
util
complex
character
two
complementari
method
dot
blot
qrtpcr
anoth
import
control
particularli
human
system
replic
ontarget
effect
least
two
cell
line
though
control
perform
limit
number
chemic
probe
mani
year
rna
label
undrugg
imposs
probe
select
howev
report
describ
herein
demonstr
substanti
progress
achiev
past
four
year
includ
develop
chemic
probe
uniqu
rna
element
though
number
target
rna
element
certain
vastli
exceed
list
archaea
exampl
unrepres
report
rnatarget
chemic
probe
despit
establish
import
small
regulatori
rna
archaea
metabol
morpholog
adapt
extrem
condit
furthermor
sever
rna
implic
diseas
novel
treatment
strategi
need
includ
insectborn
virus
genet
disord
metastat
cancer
well
bacteri
target
amid
antibioticresist
crisi
also
mani
opportun
rnatarget
fungal
system
especi
fungal
infect
experienc
rise
case
therapeut
plateau
fundament
develop
chemic
probe
allow
rapid
revers
interrog
novel
complex
rna
biolog
way
attain
knockdown
genet
approach
potenti
benefit
select
rna
target
stagger
approach
toward
chemic
probe
develop
must
thought
consid
number
variabl
includ
transcript
abund
tissuespecif
express
rna
target
total
mass
number
molecul
rrna
trna
account
greater
total
cellular
rna
human
thu
mrna
ncrna
exist
much
lower
abund
even
within
low
abund
transcript
copi
number
vari
wide
within
across
cell
type
report
mrna
level
span
four
order
magnitud
ncrna
averag
less
one
copi
per
cell
direct
impact
rna
express
level
recent
report
author
propos
ligand
occup
mirna
target
driven
rel
abund
structur
similar
rna
element
rna
welldefin
function
highli
express
thu
repres
lowhang
fruit
within
field
select
librari
primari
screen
strategi
also
critic
success
chemic
probe
discoveri
rna
target
known
structur
andor
ligand
use
focus
screen
librari
proven
effici
strategi
though
approach
gener
limit
chemic
divers
librari
advanc
identif
rnaprivileg
scaffold
biolog
relev
rna
chemic
space
facilit
discoveri
chemic
probe
addit
rna
target
effort
could
expedit
addit
fragmentor
natur
productbas
screen
access
vast
chemic
space
fewer
ligand
probe
known
biolog
relev
chemic
space
respect
addit
highthroughput
screen
could
likewis
discov
novel
chemotyp
though
expens
may
exceed
resourc
avail
academia
focus
approach
attain
continu
progress
develop
refin
comput
tool
also
aid
expand
boundari
focus
screen
structurebas
design
although
latter
also
depend
upon
advanc
accur
determin
atom
resolut
structur
addit
vitro
cellular
activitybas
assay
probe
wellstudi
rna
function
eg
splice
translat
process
may
practic
start
point
identifi
chemic
probe
includ
screen
strategi
describ
herein
well
other
recent
develop
final
numer
opportun
exist
build
upon
establish
multival
target
strategi
discuss
particularli
applic
dynam
combinatori
chemistri
rna
unknown
structur
use
chemic
probe
biolog
system
qualiti
specif
probe
must
well
character
draw
accur
meaning
conclus
recent
highlight
sever
preemin
chemic
biologist
evalu
chemic
probe
reveal
divers
spectrum
character
techniqu
ligand
meet
tradit
criteria
robust
chemic
probe
gap
attribut
lack
relev
tool
exampl
character
inconsist
includ
incomplet
report
cytotox
lack
attent
cell
permeabl
local
addit
mani
vitro
assay
access
help
establish
potenc
select
probe
multipl
experi
assay
includ
evalu
specif
mutat
target
number
structur
rna
cellbas
observ
reproduc
multipl
cell
line
valid
absenc
target
util
sirna
crisprca
technolog
ontarget
effect
establish
use
number
spatialbas
experi
includ
biochem
method
describ
herein
eg
chemclip
rip
novel
applic
technolog
incel
chemic
probe
observ
chang
rna
secondari
structur
upon
ligand
bind
photoaffin
label
assess
target
engag
tempor
control
plausibl
serial
passag
experi
follow
deep
sequenc
also
perform
even
human
system
identifi
ligandescap
mutat
confirm
target
engag
andor
offtarget
effect
lastli
critic
use
inact
analog
activ
analog
differ
chemic
class
feasibl
draw
conclus
regard
target
biolog
move
toward
standard
crucial
rnatarget
field
avoid
scientif
pollut
plagu
mani
other
comparison
note
decad
ago
chemic
probe
discoveri
anoth
undrugg
target
protein
protein
interact
infanc
known
small
molecul
inhibitor
howev
novel
advanc
screen
approach
design
strategi
led
rapid
discoveri
thousand
protein
protein
interact
inhibitor
sever
enter
clinic
also
break
rule
druglik
chemic
space
next
five
year
anticip
innov
describ
herein
one
yet
discov
lead
similar
surg
report
rnabas
chemic
probe
therapeut
also
expect
novel
wellcharacter
chemic
probe
allow
rna
biologist
uncov
mani
excit
unanticip
role
rna
propel
us
next
phase
rna
revolut
supplementari
data
avail
nar
onlin
